These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Protein misfolding and degradation in genetic diseases. Bross P; Corydon TJ; Andresen BS; Jørgensen MM; Bolund L; Gregersen N Hum Mutat; 1999; 14(3):186-98. PubMed ID: 10477427 [TBL] [Abstract][Full Text] [Related]
4. Protein Misfolding Diseases and Therapeutic Approaches. Yadav K; Yadav A; Vashistha P; Pandey VP; Dwivedi UN Curr Protein Pept Sci; 2019; 20(12):1226-1245. PubMed ID: 31187709 [TBL] [Abstract][Full Text] [Related]
5. Impaired folding and subunit assembly as disease mechanism: the example of medium-chain acyl-CoA dehydrogenase deficiency. Bross P; Andresen BS; Gregersen N Prog Nucleic Acid Res Mol Biol; 1998; 58():301-37. PubMed ID: 9308370 [TBL] [Abstract][Full Text] [Related]
6. Control of cystic fibrosis transmembrane conductance regulator membrane trafficking: not just from the endoplasmic reticulum to the Golgi. Farinha CM; Matos P; Amaral MD FEBS J; 2013 Sep; 280(18):4396-406. PubMed ID: 23773658 [TBL] [Abstract][Full Text] [Related]
7. Rapid degradation of short-chain acyl-CoA dehydrogenase variants with temperature-sensitive folding defects occurs after import into mitochondria. Corydon TJ; Bross P; Jensen TG; Corydon MJ; Lund TB; Jensen UB; Kim JJ; Gregersen N; Bolund L J Biol Chem; 1998 May; 273(21):13065-71. PubMed ID: 9582344 [TBL] [Abstract][Full Text] [Related]
8. Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein. Brown CR; Hong-Brown LQ; Biwersi J; Verkman AS; Welch WJ Cell Stress Chaperones; 1996 Jun; 1(2):117-25. PubMed ID: 9222597 [TBL] [Abstract][Full Text] [Related]
9. Therapy through chaperones: sense or antisense? Cystic fibrosis as a model disease. Amaral MD J Inherit Metab Dis; 2006; 29(2-3):477-87. PubMed ID: 16763920 [TBL] [Abstract][Full Text] [Related]
10. Base treatment corrects defects due to misfolding of mutant cystic fibrosis transmembrane conductance regulator. Namkung W; Kim KH; Lee MG Gastroenterology; 2005 Dec; 129(6):1979-90. PubMed ID: 16344066 [TBL] [Abstract][Full Text] [Related]
11. Chaperones rescue the energetic landscape of mutant CFTR at single molecule and in cell. Bagdany M; Veit G; Fukuda R; Avramescu RG; Okiyoneda T; Baaklini I; Singh J; Sovak G; Xu H; Apaja PM; Sattin S; Beitel LK; Roldan A; Colombo G; Balch W; Young JC; Lukacs GL Nat Commun; 2017 Aug; 8(1):398. PubMed ID: 28855508 [TBL] [Abstract][Full Text] [Related]
12. Endoplasmic Reticulum-Targeted Subunit Toxins Provide a New Approach to Rescue Misfolded Mutant Proteins and Revert Cell Models of Genetic Diseases. Adnan H; Zhang Z; Park HJ; Tailor C; Che C; Kamani M; Spitalny G; Binnington B; Lingwood C PLoS One; 2016; 11(12):e0166948. PubMed ID: 27935997 [TBL] [Abstract][Full Text] [Related]
13. Degradation of CFTR by the ubiquitin-proteasome pathway. Ward CL; Omura S; Kopito RR Cell; 1995 Oct; 83(1):121-7. PubMed ID: 7553863 [TBL] [Abstract][Full Text] [Related]